AXON
Price
$504.68
Change
+$2.13 (+0.42%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
39.19B
34 days until earnings call
BCAB
Price
$0.27
Change
-$0.02 (-6.90%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
15.56M
29 days until earnings call
Ad is loading...

AXON vs BCAB

Header iconAXON vs BCAB Comparison
Open Charts AXON vs BCABBanner chart's image
Axon Enterprise
Price$504.68
Change+$2.13 (+0.42%)
Volume$7.13K
Capitalization39.19B
BioAtla
Price$0.27
Change-$0.02 (-6.90%)
Volume$1.41K
Capitalization15.56M
AXON vs BCAB Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. BCAB commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and BCAB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (AXON: $502.55 vs. BCAB: $0.29)
Brand notoriety: AXON and BCAB are both not notable
AXON represents the Aerospace & Defense, while BCAB is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 113% vs. BCAB: 74%
Market capitalization -- AXON: $39.19B vs. BCAB: $15.56M
AXON [@Aerospace & Defense] is valued at $39.19B. BCAB’s [@Biotechnology] market capitalization is $15.56M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $180.65B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $15.29B. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileBCAB’s FA Score has 1 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • BCAB’s FA Score: 1 green, 4 red.
According to our system of comparison, AXON is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 3 TA indicator(s) are bullish while BCAB’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 3 bullish, 3 bearish.
  • BCAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а -4.45% price change this week, while BCAB (@Biotechnology) price change was -16.35% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -7.82%. For the same industry, the average monthly price growth was -9.82%, and the average quarterly price growth was +5.94%.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.88%. For the same industry, the average monthly price growth was -20.27%, and the average quarterly price growth was -19.68%.

Reported Earning Dates

AXON is expected to report earnings on Aug 12, 2025.

BCAB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Aerospace & Defense (-7.82% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-9.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($39.2B) has a higher market cap than BCAB($15.6M). AXON YTD gains are higher at: -15.441 vs. BCAB (-50.930). AXON has higher annual earnings (EBITDA): 437M vs. BCAB (-85.17M). AXON has more cash in the bank: 986M vs. BCAB (56.5M). BCAB has less debt than AXON: BCAB (1.25M) vs AXON (722M). AXON has higher revenues than BCAB: AXON (2.08B) vs BCAB (11M).
AXONBCABAXON / BCAB
Capitalization39.2B15.6M251,282%
EBITDA437M-85.17M-513%
Gain YTD-15.441-50.93030%
P/E Ratio105.14N/A-
Revenue2.08B11M18,936%
Total Cash986M56.5M1,745%
Total Debt722M1.25M57,714%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXONBCAB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMO0.710.05
+7.68%
Sangamo Therapeutics
PWP16.110.22
+1.38%
Perella Weinberg Partners
CF72.04-1.03
-1.41%
CF Industries Holding
QFIN36.08-2.17
-5.67%
Qifu Technology
YJ1.69-0.13
-7.14%
Yunji Inc

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+1.09%
TECH - AXON
61%
Loosely correlated
+1.14%
VCYT - AXON
58%
Loosely correlated
+2.00%
BEAM - AXON
57%
Loosely correlated
+0.20%
SEER - AXON
56%
Loosely correlated
+4.68%
ADPT - AXON
56%
Loosely correlated
+3.15%
More

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+3.53%
AXON - BCAB
41%
Loosely correlated
+1.09%
VCYT - BCAB
38%
Loosely correlated
+2.00%
CTMX - BCAB
38%
Loosely correlated
-5.29%
CRSP - BCAB
37%
Loosely correlated
-0.83%
AMLX - BCAB
37%
Loosely correlated
+0.87%
More